The analysis showed that age (> 45 years), WHO grade (G4), pathological type (glioblastoma multiformes), and IDH1 mutation status (wild type) were statistically positively associated with high TASL expression (P < 0.05) (Table 2). The gene discussed is IDH1; the disease is glioblastoma.